5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma

Experimental Dermatology

Volumn 14, Issue 6, 2005, Pages 429-437

  Cordoba F ^a   Braathen, L R ^a   Weissenberger, J ^a   Vallan, C ^a   Kato, M ^b   Nakashima, I ^c   Weis, J ^a,d   von Felbert, Verena ^a,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b KANAZAWA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

5 ALA; Melanoma; MT ret mice; PDT

Indexed keywords

AMINOLEVULINIC ACID; METALLOTHIONEIN I; PROTEIN RET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CANCER CELL CULTURE; CANCER RESISTANCE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE REGIMEN; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; TRANSGENIC MOUSE; TUMOR GROWTH;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FIBROSIS; FLOW CYTOMETRY; HUMANS; LIGHT; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NIH 3T3 CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TRYPAN BLUE;

EID: 19644387943     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00303.x     Document Type: Article

References (54)

1. Kurwa H A, Barlow R J. The role of photodynamic therapy in dermatology. Clin Exp Dermatol 1999: 24: 143-148.
2. Dolmans D E, Fukumura D, Jain R K. Photodynamic therapy for cancer. Nat Rev Cancer 2003: 3: 380-387.
3. Dougherty T J. An update on photodynamic therapy applications. J Clin Laser Med Surg 2002: 20: 3-7.
4. Granville D J, McManus B M, Hunt D W. Photodynamic therapy: shedding light on the biochemical pathways regulating porphyrin-mediated cell death. Histol Histopathol 2001: 16: 309-317.
5. Rick K, Sroka R, Stepp H et al. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B 1997: 40: 313-319.
6. Peng Q, Berg K, Moan J, Kongshaug M, Nesland J M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997: 65: 235-251.
7. Pahernik S, Langer S, Botzlar A, Dellian M, Goetz A E. Tissue distribution and penetration of 5-ALA induced fluorescence in an amelanotic melanoma after topical application. Anticancer Res 2001: 21: 59-63.
8. Lang K, Bolsen K, Stahl W et al. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J Photochem Photobiol B 2001: 65: 29-34.
9. Ziolkowski P, Symonowicz K, Osiecka B J, Rabczynski J. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice. Arch Immunol Ther Exp (Warsz) 1998: 46: 301-304.
10. Thibaut S, Bourre L, Hernot D, Rousset N, Lajat Y, Patrice T. Effects of BAPTA-AM, Forskolin, DSF and Z.VAD.fmk on PDT-induced apoptosis and m-THPC phototoxicity on B16 cells. Apoptosis 2002: 7: 99-106.
11. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T, Malik Z. Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer 1994: 56: 106-112.
12. Bourre L, Rousset N, Thibaut S, Eleouet S, Lajat Y, Patrice T. PDT effects of m-THPC and ALA, phototoxicity and apoptosis. Apoptosis 2002: 7: 221-230.
13. Urbanska K, Romanowska-Dixon B, Matuszak Z, Oszajca J, Nowak-Sliwinsk P, Stochel G. Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas. Acta Biochim Pol 2002: 49: 387-391.
14. Haddad R, Blumenfeld A, Siegal A et al. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma. Ann Surg Oncol 1998: 5: 241-247.
15. Haddad R, Kaplan O, Greenberg R, Siegal A, Skornick Y, Kashtan H. Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer. Int J Surg Investig 2000: 2: 171-178.
16. Jezek P, Nekvasil M, Skobisova E et al. Experimental photodynamic therapy with MESO-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice. Int J Cancer 2003: 103: 693-702.
17. Leunig M, Leunig A, Lankes P, Goetz A E. Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumour eradication. Int J Hyperthermia 1994: 10: 297-306.
18. Abels C, Heil P, Dellian M, Kuhnle G E, Baumgartner R, Goetz A E. In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. Br J Cancer 1994: 70: 826-833.
19. Dellian M, Richert C, Gamarra F, Goetz A E. Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers. Int J Cancer 1996: 65: 246-248.
20. Fritsch C, Abels C, Goetz A E et al. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol Chem 1997: 378: 51-57.
21. Abels C, Fritsch C, Bolsen K et al. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. J Photochem Photobiol B 1997: 40: 76-83.
22. Karrer S, Szeimies R M, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2001: 2: 229-237.
23. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000: 42: 389-413 (quiz 414-416).
24. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? [published erratum appears in J Am Acad Dermatol 1993 July; 29 (1): 41]. J Am Acad Dermatol 1993: 28: 17-21.
25. Nelson J S, McCullough J L, Berns M W. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. J Natl Cancer Inst 1988: 80: 56-60.
26. Ibbotson S H. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002: 146: 178-188.
27. Chedekel M R. Photophysics and photochemistry of melanin. In: Zeise L, Chedekel M R, Fitzpatrick T B, eds. Melanin: its role in photoprotection. Overland Parks, KS: Valdenmar Publishing Company, 1995: 11-21.
28. Busetti A, Soncin M, Jori G, Kenney M E, Rodgers M A. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy. Photochem Photobiol 1998: 68: 377-381.
29. Iwamoto T, Takahashi M, Ito M et al. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J 1991: 10: 3167-3175.
30. Kato M, Takahashi M, Akhand A A et al. Transgenic mouse model for skin malignant melanoma. Oncogene 1998: 17: 1885-1888.
31. Kao W W, Prockop D J. Proline analogue removes fibroblasts from cultured mixed cell populations. Nature 1977: 266: 63-64.
32. Vaupel P, Kelleher D K, Kruger W. Water-filtered infrared-A radiation: a novel technique to heat superficial tumors. Strahlenther Onkol 1992: 168: 633-639.
33. Kelleher D K, Thews O, Rzeznik J, Scherz A, Salomon Y, Vaupel P. Water-filtered infrared-A radiation: a novel technique for localized hyperthermia in combination with bacteriochlorophyll-based photodynamic therapy. Int J Hyperthermia 1999: 15: 467-474.
34. Kelleher D K, Thews O, Scherz A, Salomon Y, Vaupel P. Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment. Br J Cancer 2003: 89: 2333-2339.
35. Thier M, Simon R, Kruttgen A et al. Site-directed mutagenesis of human CNTF: functional analysis of recombinant variants. J Neurosci Res 1995: 40: 826-835.
36. Cheng J D, Dunbrack R L Jr, Valianou M, Rogatko A, Alpaugh R K, Weiner L M. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 2002: 62: 4767-4772.
37. Dahle J, Steen H B, Moan J. The mode of cell death induced by photodynamic treatment depends on cell density. Photochem Photobiol 1999: 70: 363-367.
38. Oleinick N L, Morris R L, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002: 1: 1-21.
39. Wyld L, Reed M W, Brown N J. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 2001: 84: 1384-1386.
40. Moor A C. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 2000: 57: 1-13.
41. Noodt B B, Berg K, Stokke T, Peng Q, Nesland J M. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 1996: 74: 22-29.
42. Nagata S, Obana A, Gohto Y, Nakajima S. Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX-S10(Na). Lasers Surg Med 2003: 33: 64-70.
43. Svanberg K, Liu D L, Wang I, Andersson-Engels S, Stenram U, Svanberg S. Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats. Br J Cancer 1996: 74: 1526-1533.
44. Reed M W, Miller F N, Wieman T J, Tseng M T, Pietsch C G. The effect of photodynamic therapy on the microcirculation. J Surg Res 1988: 45: 452-459.
45. Fingar V H, Wieman T J, Wiehle S A, Cerrito P B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 1992: 52: 4914-4921.
46. Dolmans D E, Kadambi A, Hill J S et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002: 62: 4289-4294.
47. Babilas P, Schacht V, Liebsch G et al. Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo. Br J Cancer 2003: 88: 1462-1469.
48. Gollnick S O, Liu X, Owczarczak B, Musser D A, Henderson B W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 1997: 57: 3904-3909.
49. Gollnick S O, Evans S S, Baumann H et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003: 88: 1772-1779.
50. Korbelik M, Dougherty G J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 1999: 59: 1941-1946.
51. Korbelik M, Sun J, Zeng H. Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours. Br J Cancer 2003: 88: 760-766.
52. Dai Y, Kato M, Takeda K et al. T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice. J Invest Dermatol 2001: 117: 694-701.
53. Sheleg S V, Zhavrid E A, Khodina T V et al. Photodynamic therapy with chlorin e6 for skin metastases of melanoma. Photodermatol Photoimmunol Photomed 2004: 20: 21-26.
54. Sun J, Cecic I, Parkins C S, Korbelik M. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem Photobiol Sci 2002: 1: 690-695.